Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Or

Showing results (211-220 of 256) with videos related to

Pageof 26
Sort By:
British Journal of Haematology|August 1, 1996
Second transplantation using allogeneic peripheral blood stem cells in a beta-thalassaemia major patient featuring stable mixed chimaerismR Or, J Kapelushnik, E Naparstek, et al.
Transplantation Proceedings|February 1, 1987
Allogeneic bone marrow transplantation without graft-v-host disease: true tolerance of graft against the host through depletion of donor T lymphocytes pregrafting in malignant and nonmalignant disordersS Slavin, R Or, E Naparstek, et al.
Transplantation Proceedings|February 1, 1989
Cytomegalovirus infection and disease after T cell depleted allogeneic bone marrow transplantation for malignant hematologic diseasesD Engelhard, R Or, N Strauss, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 21, 2006
Fludarabine-based reduced intensity conditioning for stem cell transplantation of Fanconi anemia patients from fully matched related and unrelated donorsM Bitan, R Or, M Y Shapira, et al.
British Journal of Haematology|March 1, 1995
T-cell-depleted allogeneic bone marrow transplantation for acute leukaemia using Campath-1 antibodies and post-transplant administration of donor's peripheral blood lymphocytes for prevention of relapseE Naparstek, R Or, A Nagler, et al.
American Journal of Hematology|October 31, 2003
Rhinolalia as a presenting sign of pneumomediastinum complicating post peripheral blood stem cell transplantation bronchiolitis obliteransM Bitan, I B Resnick, R Or, et al.
Bone Marrow Transplantation|November 13, 2007
Time to engraftment following allogeneic stem cell transplantation is significantly longer in patients with myelodysplastic syndrome than with acute myeloid leukemiaM Bitan, R Or, M Y Shapira, et al.
Transplantation Proceedings|February 1, 1989
The use of total lymphoid irradiation (TLI) for prevention of rejection of T-lymphocyte depleted bone marrow allografts in non-malignant hematological disordersS Slavin, E Naparstek, M Aker, et al.
Bone Marrow Transplantation|October 1, 1995
Cytosine arabinoside as a major risk factor for Streptococcus viridans septicemia following bone marrow transplantation: a 5-year prospective studyD Engelhard, H Elishoov, R Or, et al.
Lancet (London, England)|September 1, 1984
Elimination of graft-versus-host disease by in-vitro depletion of alloreactive lymphocytes with a monoclonal rat anti-human lymphocyte antibody (CAMPATH-1)H Waldmann, A Polliak, G Hale, et al.
Pageof 26

Showing results (211-220 of 256) with videos related to

Sort By:
Pageof 26
British Journal of Haematology|August 1, 1996
Second transplantation using allogeneic peripheral blood stem cells in a beta-thalassaemia major patient featuring stable mixed chimaerismR Or, J Kapelushnik, E Naparstek, et al.
Transplantation Proceedings|February 1, 1987
Allogeneic bone marrow transplantation without graft-v-host disease: true tolerance of graft against the host through depletion of donor T lymphocytes pregrafting in malignant and nonmalignant disordersS Slavin, R Or, E Naparstek, et al.
Transplantation Proceedings|February 1, 1989
Cytomegalovirus infection and disease after T cell depleted allogeneic bone marrow transplantation for malignant hematologic diseasesD Engelhard, R Or, N Strauss, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 21, 2006
Fludarabine-based reduced intensity conditioning for stem cell transplantation of Fanconi anemia patients from fully matched related and unrelated donorsM Bitan, R Or, M Y Shapira, et al.
British Journal of Haematology|March 1, 1995
T-cell-depleted allogeneic bone marrow transplantation for acute leukaemia using Campath-1 antibodies and post-transplant administration of donor's peripheral blood lymphocytes for prevention of relapseE Naparstek, R Or, A Nagler, et al.
American Journal of Hematology|October 31, 2003
Rhinolalia as a presenting sign of pneumomediastinum complicating post peripheral blood stem cell transplantation bronchiolitis obliteransM Bitan, I B Resnick, R Or, et al.
Bone Marrow Transplantation|November 13, 2007
Time to engraftment following allogeneic stem cell transplantation is significantly longer in patients with myelodysplastic syndrome than with acute myeloid leukemiaM Bitan, R Or, M Y Shapira, et al.
Transplantation Proceedings|February 1, 1989
The use of total lymphoid irradiation (TLI) for prevention of rejection of T-lymphocyte depleted bone marrow allografts in non-malignant hematological disordersS Slavin, E Naparstek, M Aker, et al.
Bone Marrow Transplantation|October 1, 1995
Cytosine arabinoside as a major risk factor for Streptococcus viridans septicemia following bone marrow transplantation: a 5-year prospective studyD Engelhard, H Elishoov, R Or, et al.
Lancet (London, England)|September 1, 1984
Elimination of graft-versus-host disease by in-vitro depletion of alloreactive lymphocytes with a monoclonal rat anti-human lymphocyte antibody (CAMPATH-1)H Waldmann, A Polliak, G Hale, et al.
Pageof 26